These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 30466803

  • 1. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL, Neely ML, Finlen Copeland CA, Frankel CW, Reynolds JM, Palmer SM.
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [Abstract] [Full Text] [Related]

  • 2. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A, Todd JL, Zhang A, Li N, Mayalall A, Finlen Copeland CA, Shino M, Pavlisko EN, Wallace WD, Gregson A, Ross DJ, Saggar R, Lynch JP, Belperio J, Snyder LD, Palmer SM, Weigt SS.
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [Abstract] [Full Text] [Related]

  • 3. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A, Verleden SE, Sacreas A, Heigl T, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck D, Verleden GM, Vos R.
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [Abstract] [Full Text] [Related]

  • 4. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, Keshavjee S.
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G, Lauseker M, Howanietz AS, Milger K, Veit T, Munker D, Schneider C, Weig T, Michel S, Barton J, Meiser B, Dinkel J, Neurohr C, Behr J, Kneidinger N.
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [Abstract] [Full Text] [Related]

  • 6. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
    Todd JL, Jain R, Pavlisko EN, Finlen Copeland CA, Reynolds JM, Snyder LD, Palmer SM.
    Am J Respir Crit Care Med; 2014 Jan 15; 189(2):159-66. PubMed ID: 24325429
    [Abstract] [Full Text] [Related]

  • 7. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.
    Sato M, Hwang DM, Ohmori-Matsuda K, Chaparro C, Waddell TK, Singer LG, Hutcheon MA, Keshavjee S.
    J Heart Lung Transplant; 2012 Apr 15; 31(4):354-63. PubMed ID: 22330935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T, Horie M, Sato M, Nakajima D, Shoushtarizadeh H, Binnie M, Azad S, Hwang DM, Machuca TN, Waddell TK, Singer LG, Cypel M, Liu M, Paul NS, Keshavjee S.
    J Heart Lung Transplant; 2016 Jan 15; 35(1):59-66. PubMed ID: 26342441
    [Abstract] [Full Text] [Related]

  • 11. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C, Haughton M, Leonard S, Huber LC.
    J Heart Lung Transplant; 2017 Sep 15; 36(9):921-933. PubMed ID: 28662986
    [Abstract] [Full Text] [Related]

  • 12. Montelukast in chronic lung allograft dysfunction after lung transplantation.
    Vos R, Eynde RV, Ruttens D, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM, Leuven Lung Transplant Group.
    J Heart Lung Transplant; 2019 May 15; 38(5):516-527. PubMed ID: 30638839
    [Abstract] [Full Text] [Related]

  • 13. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M, Salazar P, Saito T, Binnie M, Brock K, Yasufuku K, Azad S, Keshavjee S, Martinu T, Paul N.
    Clin Transplant; 2018 May 15; 32(5):e13233. PubMed ID: 29637624
    [Abstract] [Full Text] [Related]

  • 14. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L, Huszti E, Renaud-Picard B, Berra G, Kawashima M, Takahagi A, Fuchs E, Ghany R, Moshkelgosha S, Keshavjee S, Singer LG, Tikkanen J, Martinu T.
    J Heart Lung Transplant; 2020 Aug 15; 39(8):761-770. PubMed ID: 32418864
    [Abstract] [Full Text] [Related]

  • 15. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
    Gottlieb J, Verleden GM, Perchl M, Valtin C, Vallee A, Brugière O, Bravo C.
    PLoS One; 2021 Aug 15; 16(12):e0260881. PubMed ID: 34941934
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
    Woodrow JP, Shlobin OA, Barnett SD, Burton N, Nathan SD.
    J Heart Lung Transplant; 2010 Oct 15; 29(10):1159-64. PubMed ID: 20580267
    [Abstract] [Full Text] [Related]

  • 18. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M, Ohmori-Matsuda K, Saito T, Matsuda Y, Hwang DM, Waddell TK, Singer LG, Keshavjee S.
    J Heart Lung Transplant; 2013 May 15; 32(5):484-91. PubMed ID: 23433813
    [Abstract] [Full Text] [Related]

  • 19. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE, Vandermeulen E, Ruttens D, Vos R, Vaneylen A, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM, Verleden GM.
    Semin Respir Crit Care Med; 2013 Jun 15; 34(3):352-60. PubMed ID: 23821509
    [Abstract] [Full Text] [Related]

  • 20. Restrictive chronic lung allograft dysfunction: Where are we now?
    Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Van Raemdonck DE, Dupont LJ, Vanaudenaerde BM, Verleden G, Vos R.
    J Heart Lung Transplant; 2015 May 15; 34(5):625-30. PubMed ID: 25577564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.